Medtronic still eyeing modest year-over-year growth as fiscal 2023 kicks off with slipping revenues

A year ago, even while grappling with the discontinuation of its HeartWare ventricular assist pump and the onset of the delta variant of the COVID-19 pandemic, Medtronic was still able to open its fiscal year 2022 with a major win: It clocked a revenue increase of nearly 20% compared to the same period the previous year.